HRP20200815T1 - Farmaceutski pripravak za liječenje mikoze - Google Patents
Farmaceutski pripravak za liječenje mikoze Download PDFInfo
- Publication number
- HRP20200815T1 HRP20200815T1 HRP20200815TT HRP20200815T HRP20200815T1 HR P20200815 T1 HRP20200815 T1 HR P20200815T1 HR P20200815T T HRP20200815T T HR P20200815TT HR P20200815 T HRP20200815 T HR P20200815T HR P20200815 T1 HRP20200815 T1 HR P20200815T1
- Authority
- HR
- Croatia
- Prior art keywords
- pharmaceutical preparation
- use according
- candida
- candidiasis
- preparation
- Prior art date
Links
- 206010017533 Fungal infection Diseases 0.000 title claims 4
- 208000024386 fungal infectious disease Diseases 0.000 title claims 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 16
- 241000222122 Candida albicans Species 0.000 claims 6
- YTAOBBFIOAEMLL-REQDGWNSSA-N Luliconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@H](CS\1)SC/1=C(\C#N)N1C=NC=C1 YTAOBBFIOAEMLL-REQDGWNSSA-N 0.000 claims 6
- 201000003984 candidiasis Diseases 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 206010007134 Candida infections Diseases 0.000 claims 5
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 claims 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 4
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 claims 4
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 claims 4
- 239000006071 cream Substances 0.000 claims 4
- 229960003913 econazole Drugs 0.000 claims 4
- 229960002509 miconazole Drugs 0.000 claims 4
- MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 claims 3
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 claims 3
- ZCJYUTQZBAIHBS-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C=CC(SC=2C=CC=CC=2)=CC=1)CN1C=NC=C1 ZCJYUTQZBAIHBS-UHFFFAOYSA-N 0.000 claims 3
- 229960005074 butoconazole Drugs 0.000 claims 3
- SWLMUYACZKCSHZ-UHFFFAOYSA-N butoconazole Chemical compound C1=CC(Cl)=CC=C1CCC(SC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 SWLMUYACZKCSHZ-UHFFFAOYSA-N 0.000 claims 3
- 229960001274 fenticonazole Drugs 0.000 claims 3
- 229960004849 isoconazole Drugs 0.000 claims 3
- 229960002607 sulconazole Drugs 0.000 claims 3
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims 2
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 claims 2
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 claims 2
- JLGKQTAYUIMGRK-UHFFFAOYSA-N 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 JLGKQTAYUIMGRK-UHFFFAOYSA-N 0.000 claims 2
- 241000222178 Candida tropicalis Species 0.000 claims 2
- 229960000333 benzydamine Drugs 0.000 claims 2
- 229960002206 bifonazole Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229960004022 clotrimazole Drugs 0.000 claims 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- 229960004125 ketoconazole Drugs 0.000 claims 2
- 239000006210 lotion Substances 0.000 claims 2
- 229960004031 omoconazole Drugs 0.000 claims 2
- JMFOSJNGKJCTMJ-ZHZULCJRSA-N omoconazole Chemical compound C1=CN=CN1C(/C)=C(C=1C(=CC(Cl)=CC=1)Cl)\OCCOC1=CC=C(Cl)C=C1 JMFOSJNGKJCTMJ-ZHZULCJRSA-N 0.000 claims 2
- -1 pomade Substances 0.000 claims 2
- 229960005429 sertaconazole Drugs 0.000 claims 2
- 229960004214 tioconazole Drugs 0.000 claims 2
- 241000144583 Candida dubliniensis Species 0.000 claims 1
- 241000222173 Candida parapsilosis Species 0.000 claims 1
- 241001508813 Clavispora lusitaniae Species 0.000 claims 1
- WHPAGCJNPTUGGD-UHFFFAOYSA-N Croconazole Chemical compound ClC1=CC=CC(COC=2C(=CC=CC=2)C(=C)N2C=NC=C2)=C1 WHPAGCJNPTUGGD-UHFFFAOYSA-N 0.000 claims 1
- 241000222175 Diutina rugosa Species 0.000 claims 1
- 208000010195 Onychomycosis Diseases 0.000 claims 1
- 206010042938 Systemic candida Diseases 0.000 claims 1
- 241000222126 [Candida] glabrata Species 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 208000002479 balanitis Diseases 0.000 claims 1
- 229940095731 candida albicans Drugs 0.000 claims 1
- 208000032343 candida glabrata infection Diseases 0.000 claims 1
- 229940055022 candida parapsilosis Drugs 0.000 claims 1
- 229960000849 chlormidazole Drugs 0.000 claims 1
- WNAQOLSMVPFGTE-UHFFFAOYSA-N chlormidazole Chemical compound CC1=NC2=CC=CC=C2N1CC1=CC=C(Cl)C=C1 WNAQOLSMVPFGTE-UHFFFAOYSA-N 0.000 claims 1
- 229960002042 croconazole Drugs 0.000 claims 1
- 208000005035 cutaneous candidiasis Diseases 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000000642 iatrogenic effect Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- VWOIKFDZQQLJBJ-DTQAZKPQSA-N neticonazole Chemical compound CCCCCOC1=CC=CC=C1\C(=C/SC)N1C=NC=C1 VWOIKFDZQQLJBJ-DTQAZKPQSA-N 0.000 claims 1
- 229950010757 neticonazole Drugs 0.000 claims 1
- 229960003483 oxiconazole Drugs 0.000 claims 1
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 239000011885 synergistic combination Substances 0.000 claims 1
- 201000005882 tinea unguium Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Claims (15)
1. Farmaceutski pripravak, naznačen time, da obuhvaća sinergističku kombinaciju benzidamina i imidazol-antimikotika ili njegove soli, te najmanje jedno farmaceutski prihvatljivo pomoćno sredstvo, te time, da se upotrebljava u liječenju Candida-mikoze.
2. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 1, naznačen time, da je navedeni imidazol-antimikotik odabran iz skupine koja obuhvaća sljedeće: bifonazol, butokonazol, klormidazol, klotrimazol, krokonazol, ekonazol, fentikonazol, ketokonazol, izokonazol, mikonazol, netikonazol, omokonazol, oksikonazol, sertakonazol, sulkonazol, tiokonazol ili njihove soli.
3. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 2, naznačen time, da je navedeni imidazol-antimikotik odabran iz skupine koja obuhvaća sljedeće: bifonazol, butokonazol, klotrimazol, ekonazol, fentikonazol, ketokonazol, izokonazol, mikonazol, omokonazol, sertakonazol, sulkonazol, tiokonazol ili njihove soli.
4. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 3, naznačen time, da je navedeni imidazol-antimikotik odabran iz skupine koja obuhvaća sljedeće: butokonazol, ekonazol, fentikonazol, izokonazol, mikonazol, sulkonazol ili njihove soli.
5. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 4, naznačen time, da navedeni imidazol-antimikotik je ekonazol, mikonazol ili njihove soli.
6. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 1, naznačen time, da je navedena Candida-mikoza uzrokovana Candida-sojevima odabranima iz skupine koju čine sljedeći: Candida albicans, Candida lusitaniae, Candida tropicalis, Candida glabrata, Candida rugosa, Candida parapsilosis, Candida tropicalis i Candida dubliniensis.
7. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 6, naznačen time, da navedena Candida-mikoza je mukozna kandidijaza, kožna kandidijaza, onikomikoza, sustavna kandidijaza, iatrogena kandidijaza, pelenska kandidijaza, crijevna kandidijaza ili kandida balanitis.
8. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 7, naznačen time, da navedena mukozna kandidijaza je oralna ili vulvovaginalna.
9. Farmaceutski pripravak za uporabu prema bilo kojem od patentnih zahtjeva 1 do 8, naznačen time, da je navedeni pripravak za topikalnu uporabu.
10. Farmaceutski pripravak za uporabu prema bilo kojem od patentnih zahtjeva 1 do 9, naznačen time, da je navedeni pripravak u obliku kreme, pomade, losiona, gela, pjene, vaginaleta, vaginaleta s produljenim oslobađanjem, sredstva za vaginalnu njegu ili otopine za vanjsku uporabu.
11. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 10, naznačen time, da je navedeni pripravak u obliku kreme, pomade, losiona, sredstva za vaginalnu njegu ili otopine za vanjsku uporabu.
12. Farmaceutski pripravak za uporabu prema patentnom zahtjevu 11, naznačen time, da navedeni pripravak je krema ili sredstvo za vaginalnu njegu.
13. Farmaceutski pripravak za uporabu prema bilo kojem od patentnih zahtjeva 1 do 12, naznačen time, da se benzidamin nalazi u količini od 0,001 do 1 masenog %, još poželjnije od 0,05 do 0,5 masenih %, te čak najpoželjnije od 0,08 do 0,2 masena %.
14. Farmaceutski pripravak za uporabu prema bilo kojem od patentnih zahtjeva 1 do 12, naznačen time, da se imidazol-antimikotik ili njegova sol nalazi u količini od 0,01 do 4 masena %, još poželjnije od 0,1 do 2 masena %, te čak najpoželjnije od 0,5 do 1,5 masenih %.
15. Farmaceutski pripravak za uporabu prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time, da je navedeni farmaceutski pripravak u obliku kreme koja sadrži jedan ili više emulgatora koji posjeduju HLB-vrijednost u rasponu od 6 do 9 te jedan ili više emulgatora koji imaju HLB-vrijednost u rasponu većem od 9 do 12.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15150904 | 2015-01-13 | ||
PCT/EP2016/050272 WO2016113194A1 (en) | 2015-01-13 | 2016-01-08 | Pharmaceutical composition for the treatment of mycosis |
EP16700189.0A EP3244889B1 (en) | 2015-01-13 | 2016-01-08 | Pharmaceutical composition for the treatment of mycosis |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20200815T1 true HRP20200815T1 (hr) | 2020-08-07 |
Family
ID=52396443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20200815TT HRP20200815T1 (hr) | 2015-01-13 | 2020-05-19 | Farmaceutski pripravak za liječenje mikoze |
Country Status (29)
Country | Link |
---|---|
US (1) | US9962372B2 (hr) |
EP (1) | EP3244889B1 (hr) |
JP (1) | JP6714597B2 (hr) |
KR (1) | KR102606081B1 (hr) |
CN (1) | CN107106690B (hr) |
AR (1) | AR103381A1 (hr) |
AU (1) | AU2016208200B2 (hr) |
BR (1) | BR112017014295B1 (hr) |
CA (1) | CA2970060C (hr) |
CY (1) | CY1122979T1 (hr) |
DK (1) | DK3244889T3 (hr) |
EA (1) | EA035748B1 (hr) |
ES (1) | ES2794824T3 (hr) |
GE (1) | GEP20196962B (hr) |
HK (1) | HK1246146A1 (hr) |
HR (1) | HRP20200815T1 (hr) |
HU (1) | HUE049877T2 (hr) |
IL (1) | IL252774A0 (hr) |
LT (1) | LT3244889T (hr) |
MD (1) | MD3244889T2 (hr) |
ME (1) | ME03736B (hr) |
MX (1) | MX2017008879A (hr) |
PL (1) | PL3244889T3 (hr) |
PT (1) | PT3244889T (hr) |
RS (1) | RS60508B1 (hr) |
SG (1) | SG11201704964RA (hr) |
SI (1) | SI3244889T1 (hr) |
UA (1) | UA120864C2 (hr) |
WO (1) | WO2016113194A1 (hr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA037435B1 (ru) * | 2016-07-08 | 2021-03-26 | Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. | Фармацевтическая композиция, содержащая бензидамин |
CN112514904B (zh) * | 2021-01-26 | 2021-10-26 | 青岛农业大学 | 盐酸苄达明在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224598D0 (en) | 1992-11-24 | 1993-01-13 | Smithkline Beecham Plc | Novel compositions |
IT1274655B (it) * | 1995-02-28 | 1997-07-18 | Smithkline Beecham Farma | Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico |
US6913759B2 (en) * | 2003-03-11 | 2005-07-05 | Curatek Pharmaceuticals Holding, Inc. | Gel composition and method for treatment of vaginal infections |
PL2018164T3 (pl) * | 2006-05-12 | 2017-08-31 | Christian Noe | Zastosowanie preparatów złożonych obejmujących środki przeciwgrzybicze |
CN1887352A (zh) * | 2006-07-13 | 2007-01-03 | 徐艳 | 治疗眼部真菌和细菌感染的组合物 |
GB201000196D0 (en) * | 2010-01-07 | 2010-02-24 | Galvez Julian M | Novel combination |
-
2016
- 2016-01-08 CA CA2970060A patent/CA2970060C/en active Active
- 2016-01-08 US US15/541,245 patent/US9962372B2/en active Active
- 2016-01-08 LT LTEP16700189.0T patent/LT3244889T/lt unknown
- 2016-01-08 AU AU2016208200A patent/AU2016208200B2/en active Active
- 2016-01-08 WO PCT/EP2016/050272 patent/WO2016113194A1/en active Application Filing
- 2016-01-08 HU HUE16700189A patent/HUE049877T2/hu unknown
- 2016-01-08 MD MDE20170279T patent/MD3244889T2/ro unknown
- 2016-01-08 RS RS20200615A patent/RS60508B1/sr unknown
- 2016-01-08 JP JP2017535653A patent/JP6714597B2/ja active Active
- 2016-01-08 SG SG11201704964RA patent/SG11201704964RA/en unknown
- 2016-01-08 MX MX2017008879A patent/MX2017008879A/es unknown
- 2016-01-08 EA EA201791483A patent/EA035748B1/ru unknown
- 2016-01-08 EP EP16700189.0A patent/EP3244889B1/en active Active
- 2016-01-08 UA UAA201705952A patent/UA120864C2/uk unknown
- 2016-01-08 PL PL16700189T patent/PL3244889T3/pl unknown
- 2016-01-08 DK DK16700189.0T patent/DK3244889T3/da active
- 2016-01-08 GE GEAP201614557A patent/GEP20196962B/en unknown
- 2016-01-08 CN CN201680004851.0A patent/CN107106690B/zh active Active
- 2016-01-08 BR BR112017014295-3A patent/BR112017014295B1/pt active IP Right Grant
- 2016-01-08 ES ES16700189T patent/ES2794824T3/es active Active
- 2016-01-08 PT PT167001890T patent/PT3244889T/pt unknown
- 2016-01-08 SI SI201630773T patent/SI3244889T1/sl unknown
- 2016-01-08 AR ARP160100043A patent/AR103381A1/es unknown
- 2016-01-08 KR KR1020177019214A patent/KR102606081B1/ko active IP Right Grant
- 2016-01-08 ME MEP-2020-100A patent/ME03736B/me unknown
-
2017
- 2017-06-08 IL IL252774A patent/IL252774A0/en active IP Right Grant
-
2018
- 2018-04-24 HK HK18105346.0A patent/HK1246146A1/zh unknown
-
2020
- 2020-05-19 HR HRP20200815TT patent/HRP20200815T1/hr unknown
- 2020-06-02 CY CY20201100519T patent/CY1122979T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20200815T1 (hr) | Farmaceutski pripravak za liječenje mikoze | |
JP2012505171A5 (hr) | ||
JP2011500779A5 (hr) | ||
JP2014505733A5 (hr) | ||
RU2017114355A (ru) | Производные нафтиридина в качестве антагонистов альфа v бета 6 интегрина для лечения, в частности, фиброзных заболеваний | |
US20080317737A1 (en) | Drug combination for the treatment of skin disorders | |
CA2556815A1 (en) | Skincare compositions comprising salicylic acid | |
SI2989100T1 (en) | NAFTIRIDINE DERIVATIVES USED AS ANTAGONISTS INTEGRITY OF ALFA-V-BETA-6 | |
BRPI0112725B1 (pt) | Composição de verniz para unhas. | |
AR065886A1 (es) | Producto de cuidado bucal y metodos de uso y fabricacion del mismo | |
CA2705815A1 (en) | Topical drugs for use in antifungal therapy | |
WO2012052536A3 (en) | Cosmetic composition comprising aloe vera and an isethionic acid derivative | |
JP2017519036A5 (hr) | ||
US20110082118A1 (en) | Onychomycosis Treatment Delivery System | |
JP2017536382A5 (hr) | ||
AR065317A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
RU2011103256A (ru) | Крем-пена для ухода за кожей | |
JP2017529377A5 (hr) | ||
FI3197431T3 (fi) | Vaahtoa muodostavia koostumuksia ja menetelmiä aktiivisen agenssin toimittamiseksi kehon onteloon | |
US20110076261A1 (en) | Antifungal Drug Delivery System | |
JP2019526631A5 (hr) | ||
RU2018125252A (ru) | Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции | |
EP2737902A1 (en) | Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field | |
Huang et al. | A case of tinea versicolor of the eyelids |